Laser treatment of transitional cell cancer of the bladder and upper urinary tract.

Eduardo Orihuela, A. D. Smith

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Nd:YAG laser therapy now has a well-defined role in the treatment of superficial bladder cancer, that is, it is indicated only when one needs to destroy present tumors. Available results suggest that tumor recurrence is reduced, but definitive evidence of this is lacking. The laser's main advantage is that the procedure is carried out without anesthesia on an outpatient basis, because it is a noncontact technique that is associated with minimal morbidity and reduced pain and bleeding. Nd:YAG laser use in invasive bladder cancer would appear to be adequate for palliation only. For this indication, its benefits must be compared with conventional palliative TUR and/or radiation therapy. Laser therapy of tumors in the upper urinary tract is still in its infancy. Urothelial cancer is a multifocal disease, and the critical caveat, as in the case of bladder cancer, is tumor recurrence. Routine access to the upper tract and accurate assessment of the grade and stage of the tumor and the multifocality of the disease are of paramount importance and are not yet perfected. Photodynamic therapy is an intriguing modality. It has much potential for future development, but at present, because of its reduced ability to control superficial cancer, particularly when compared with other available forms of treatment such as intravesical BCG, and because of its significant associated morbidity, its use remains investigational.

Original languageEnglish
Pages (from-to)123-142
Number of pages20
JournalCancer Treatment and Research
Volume46
StatePublished - 1989
Externally publishedYes

Fingerprint

Urinary Tract
Urinary Bladder Neoplasms
Lasers
Neoplasms
Solid-State Lasers
Laser Therapy
Therapeutics
Morbidity
Recurrence
Aptitude
Photochemotherapy
Mycobacterium bovis
Palliative Care
Outpatients
Radiotherapy
Anesthesia
Hemorrhage
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Laser treatment of transitional cell cancer of the bladder and upper urinary tract. / Orihuela, Eduardo; Smith, A. D.

In: Cancer Treatment and Research, Vol. 46, 1989, p. 123-142.

Research output: Contribution to journalArticle

@article{e84834b8c61a47839c66871b5d7ed5ec,
title = "Laser treatment of transitional cell cancer of the bladder and upper urinary tract.",
abstract = "Nd:YAG laser therapy now has a well-defined role in the treatment of superficial bladder cancer, that is, it is indicated only when one needs to destroy present tumors. Available results suggest that tumor recurrence is reduced, but definitive evidence of this is lacking. The laser's main advantage is that the procedure is carried out without anesthesia on an outpatient basis, because it is a noncontact technique that is associated with minimal morbidity and reduced pain and bleeding. Nd:YAG laser use in invasive bladder cancer would appear to be adequate for palliation only. For this indication, its benefits must be compared with conventional palliative TUR and/or radiation therapy. Laser therapy of tumors in the upper urinary tract is still in its infancy. Urothelial cancer is a multifocal disease, and the critical caveat, as in the case of bladder cancer, is tumor recurrence. Routine access to the upper tract and accurate assessment of the grade and stage of the tumor and the multifocality of the disease are of paramount importance and are not yet perfected. Photodynamic therapy is an intriguing modality. It has much potential for future development, but at present, because of its reduced ability to control superficial cancer, particularly when compared with other available forms of treatment such as intravesical BCG, and because of its significant associated morbidity, its use remains investigational.",
author = "Eduardo Orihuela and Smith, {A. D.}",
year = "1989",
language = "English",
volume = "46",
pages = "123--142",
journal = "Cancer Treatment and Research",
issn = "0927-3042",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Laser treatment of transitional cell cancer of the bladder and upper urinary tract.

AU - Orihuela, Eduardo

AU - Smith, A. D.

PY - 1989

Y1 - 1989

N2 - Nd:YAG laser therapy now has a well-defined role in the treatment of superficial bladder cancer, that is, it is indicated only when one needs to destroy present tumors. Available results suggest that tumor recurrence is reduced, but definitive evidence of this is lacking. The laser's main advantage is that the procedure is carried out without anesthesia on an outpatient basis, because it is a noncontact technique that is associated with minimal morbidity and reduced pain and bleeding. Nd:YAG laser use in invasive bladder cancer would appear to be adequate for palliation only. For this indication, its benefits must be compared with conventional palliative TUR and/or radiation therapy. Laser therapy of tumors in the upper urinary tract is still in its infancy. Urothelial cancer is a multifocal disease, and the critical caveat, as in the case of bladder cancer, is tumor recurrence. Routine access to the upper tract and accurate assessment of the grade and stage of the tumor and the multifocality of the disease are of paramount importance and are not yet perfected. Photodynamic therapy is an intriguing modality. It has much potential for future development, but at present, because of its reduced ability to control superficial cancer, particularly when compared with other available forms of treatment such as intravesical BCG, and because of its significant associated morbidity, its use remains investigational.

AB - Nd:YAG laser therapy now has a well-defined role in the treatment of superficial bladder cancer, that is, it is indicated only when one needs to destroy present tumors. Available results suggest that tumor recurrence is reduced, but definitive evidence of this is lacking. The laser's main advantage is that the procedure is carried out without anesthesia on an outpatient basis, because it is a noncontact technique that is associated with minimal morbidity and reduced pain and bleeding. Nd:YAG laser use in invasive bladder cancer would appear to be adequate for palliation only. For this indication, its benefits must be compared with conventional palliative TUR and/or radiation therapy. Laser therapy of tumors in the upper urinary tract is still in its infancy. Urothelial cancer is a multifocal disease, and the critical caveat, as in the case of bladder cancer, is tumor recurrence. Routine access to the upper tract and accurate assessment of the grade and stage of the tumor and the multifocality of the disease are of paramount importance and are not yet perfected. Photodynamic therapy is an intriguing modality. It has much potential for future development, but at present, because of its reduced ability to control superficial cancer, particularly when compared with other available forms of treatment such as intravesical BCG, and because of its significant associated morbidity, its use remains investigational.

UR - http://www.scopus.com/inward/record.url?scp=0024794423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024794423&partnerID=8YFLogxK

M3 - Article

C2 - 2577185

AN - SCOPUS:0024794423

VL - 46

SP - 123

EP - 142

JO - Cancer Treatment and Research

JF - Cancer Treatment and Research

SN - 0927-3042

ER -